Jennifer Plummer
About Jennifer Plummer
Jennifer Plummer is a Clinical Operations Manager and Protocol Risk Assessment Coordinator with extensive experience in clinical operations and program analysis. She has worked at Axle Informatics since 2021 and previously held positions at Columbus Technologies and Services and The Henry M. Jackson Foundation, earning multiple awards for her contributions to the field.
Work at Axle Informatics
Jennifer Plummer currently serves as the Clinical Operations Manager and Protocol Risk Assessment Coordinator at Axle Informatics. She has held this position since 2021, contributing to clinical operations in Rockville, Maryland. In her role, she focuses on protocol risk assessment and management, ensuring compliance and efficiency in clinical operations.
Previous Experience at Columbus Technologies and Services
Prior to her current role, Jennifer worked at Columbus Technologies and Services as a Clinical Operations Manager from 2016 to 2021. During her five years in this position, she was responsible for overseeing clinical operations and enhancing program effectiveness in Rockville, Maryland.
Background in Clinical Operations and Risk Assessment
Jennifer has extensive experience in clinical operations and risk assessment. She worked as a Program Analyst and Protocol Risk Coordinator at The Henry M. Jackson Foundation for the Advancement of Military Medicine from 2009 to 2016. Her responsibilities included protocol risk management and supporting clinical research initiatives.
Education and Expertise
Jennifer is currently pursuing studies in Business, Management, Marketing, and Related Support Services at the University of Maryland Global Campus, a program she has been enrolled in since 2013. She previously studied Business Administration and Management at Strayer University from 2006 to 2009, where she earned her degree.
Achievements and Awards
Throughout her career, Jennifer has received several awards, including the NIAID Merit Award in 2017 and 2020, recognizing her contributions to the National Institute of Allergy and Infectious Diseases. She also received the Distinguished Achievement Award in 2017, 2018, and 2020, highlighting her consistent performance and impact in her roles.